Policy-Relevant Timing
The hub is built for Hong Kong’s current reform moment: formulary updates, IMACE, and the wider need for transparent health economic evidence.
Health Technology Assessment Collaboration Hub
HTAHUB connects health economics, public health, clinical science, epidemiology, patient perspectives, pharmacology, ethics, governance, and policy expertise to support better decisions on medicines, diagnostics, devices, digital health, and models of care.
Why Now
Population ageing, rising health expenditure, high-cost medicines, new diagnostics, medical devices, and digital health technologies are increasing pressure on the sustainability and fairness of the health system.
Why HTAHUB
For collaborators, the value of HTAHUB is practical: one credible academic platform that can connect methods, policy, clinical expertise, patient perspectives, and implementation science for Hong Kong.
The hub is built for Hong Kong’s current reform moment: formulary updates, IMACE, and the wider need for transparent health economic evidence.
HTA is more than economics, combining clinical evidence, public health, patient-reported outcomes, governance, ethics, and real-world implementation.
The platform connects expertise across HKU academic units spanning public health, pharmacology and pharmacy, medicine, governance and policy, and health innovation.
Advancing Hong Kong’s international visibility and influence while positioning HKU within global HTA networks.
Short courses, workshops, videos, postgraduate engagement, and annual events help build the next generation of HTA practitioners.
Partners can work with the hub on evidence generation, technology adoption, reimbursement, training, patient engagement, and regional knowledge exchange.
Three Pillars
HTAHUB is designed to be a collaborative platform that connects stakeholders and harnesses expertise across HKU and Hong Kong to advance health technology assessment.
Methodological and applied HTA research, including economic evaluation, modelling, real-world evidence, thresholds, equity, reimbursement, and early HTA.
Short courses, seminars, workshops, postgraduate engagement, and public-facing explainers for decision-makers, professionals, students, and the public.
Connections across HKU, government, Hospital Authority, industry, insurers, providers, patient groups, civil society, and international HTA networks.
Video Learning Hub
This section is designed for people who are new to Health Technology Assessment. Short videos will explain the basic concepts, why HTA matters in Hong Kong, and how evidence can support fairer, more sustainable decisions.
A short introduction to health technologies, value, evidence, and decision-making.
Ageing, rising expenditure, high-cost technologies, formulary reform, and IMACE.
Cost-effectiveness, QALYs, thresholds, budget impact, uncertainty, and local data.
Patient-reported outcomes, social values, quality of life, and distributional impacts.
Early HTA, evidence requirements, real-world evidence, implementation, and access.
Research
HTAHUB builds on active and emerging research projects focused on Hong Kong’s policy and health-system needs.
Guidelines and toolkits for systematic incorporation of health economic methods into Hospital Authority and Health Bureau decisions.
Long-term cost and outcome models for medicines, diagnostics, interventions, technologies, and care pathways relevant to Hong Kong.
Locally grounded threshold evidence to support credible economic evaluation and interpretation in Hong Kong.
Methods that examine who benefits, who may be disadvantaged, and how health technologies affect fairness across populations.
Evidence planning for developers so promising innovations can be designed for successful health-system adoption.
Comparative effectiveness, real-world evidence synthesis, pricing, reimbursement, market access, and value-based payment models.
Focus Areas
HTAHUB focuses on themes where rigorous evidence can directly support policy, health-system adoption, and better allocation of resources in Hong Kong.
Working with innovators and research teams earlier in the technology lifecycle to clarify evidence needs, adoption pathways, value propositions, and implementation risks.
Advancing applied assessment of medicines, diagnostics, devices, digital tools, public health interventions, and models of care for Hong Kong decision-making.
Exploring how evidence, value, outcomes, incentives, and payment models can support more transparent and sustainable purchasing decisions.
Education
HTAHUB will provide targeted education for decision-makers, healthcare professionals, researchers, industry, postgraduate students, and people new to the field.
Collaborate
HTAHUB welcomes policy, academic, clinical, patient, industry, public-sector, and international collaborations.
HTA guidelines, evidence requirements, cost-effectiveness, budget impact, priority-setting frameworks, and training.
Applied economic evaluation, chronic disease modelling, comparative effectiveness, patient outcomes, and service decisions.
Early HTA, grant development, health economic modelling, real-world evidence planning, and adoption pathways.
Independent evaluation, market access evidence, value-based payment, outcomes measurement, and methodological exchange.
Patient-reported outcomes, preferences, lived experience, social values, public engagement, and equity-focused HTA.
Joint seminars, visiting speakers, comparative HTA methods, international grants, and regional capacity-building.
Team
The hub combines expertise in HTA, health economics, public health, behavioural science, infectious disease technologies, governance, policy, health systems, and international collaboration.

Associate Professor in Health Economics, Policy and Management. Leads HTA methods, economic evaluation, value frameworks, and priority setting.
Official profile →
Associate Professor and Head of Behavioural Sciences. Brings patient-reported outcomes, psycho-oncology, survivorship, and quality-of-life expertise.
Official profile →
Senior Advisor to the President's Office, Professor and Director of HKU Primary Health Care Academy, and Professor in Community Medicine and Public Health Practice. Supports public health policy, primary health care, and government engagement.
Official profile →
Associate Professor in Public Health Laboratory Sciences. Supports infectious disease genomics, pathogen evolution, genomic epidemiology, and public health translation.
Official profile →
Clinical Professor and Division Head in Health Economics, Policy and Management. Brings health economics, vaccines, and global public health expertise.
Official profile →
Principal Lecturer in Community Medicine and Public Health Practice. Supports health systems, primary care, and professional training.
Official profile →
Tutor and MPH practicum coordinator. Brings health communication, humanitarian experience, student engagement, and teaching support.
Official profile →
Director of HKU School of Governance and Policy and Kerry Group Professor in Public Policy. Supports HTA governance and institutional design.
Official profile →
Professor in Pharmacology and Pharmacy, Associate Dean of Student Affairs, Director of the Centre for Safe Medication Practice and Research, and Co-Director of the Centre for Health AI Research and Translation. Brings medication safety, big data, and pharmacoeconomics expertise.
Official profile →
Assistant Professor at HKU with expertise in life-cycle HTA, HEOR, decision analytic modelling, real-world outcomes, and health policy evaluation; Project Coordinator of SCAN 2030.
Official profile →Researchers
Researchers supporting the hub's activities.

Supports the hub's activities.

Supports the hub's activities.

Supports the hub's activities.

Supports the hub's activities.
Contact
HTAHUB welcomes conversations with policymakers, public agencies, clinicians, researchers, students, industry, patient groups, civil society, and international academic partners.